Section Navigation

The U.S. Food and Drug Administration (FDA) issued an Emergency Use Authorization (EUA) of the Pfizer- BioNTech’s COVID-19 vaccine for keiki ages 5-11. Pfizer’s data showed the vaccine is safe and 90 percent effective in preventing COVID-19 infections in this age group. Before vaccinations become available, the U.S. Centers for Disease Control and Prevention (CDC) will meet Nov. 2-3 to issue recommendations for clinical use of the vaccine. In preparation of this, we encourage parents and guardians to join us as we learn more about COVID-19 vaccinations for keiki and answer your questions!

Here are some helpful links from the presentation:

Mahalo for your interest and support; if you have appreciated the information in our COVID-19 webinar series, please consider donating to help us continue this work!

Note: Views expressed by panelists are their own and do not necessarily reflect Hawaiʻi Public Health Institute policies or positions.